Influence of diabetes mellitus on the biochemical parameters and outcomes of multiple myeloma-Reference-Cited by-同舟云学术

Influence of diabetes mellitus on the biochemical parameters and outcomes of multiple myeloma

Published:2023-02-17 Issue:1 Volume:28 Page:
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Dou Zheng-Yue¹,Xia Bing²,Wang Chao-Yu²,Xu Yan-Jie²,Zhang Yi-Zhuo²

Affiliation:

1. Department of Medical Oncology, Affiliated Hospital of Hebei University, Baoding, People’s Republic of China

2. Department of Hematology, Tianjin Medical University Cancer Institute and Hospital; National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin’s Clinical Research Center for Cancer, Tianjin, People’s Republic of China.

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/16078454.2023.2179218

Reference49 articles.

1. Efficacy and safety of once-weekly bortezomib in multiple myeloma patients

2. Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

3. Diabetes, but not pre-diabetes, is associated with shorter time to second-line therapy and worse outcomes in patients with multiple myeloma

4. Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology

5. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progress on the Status of KAP and Influencing Factors of Diabetic Patients;Advances in Clinical Medicine;2023